GBarrett

Greg has over 35 years of medical device experience. Within the medical device market he has worked in the fields of gastroenterology, urology, cardiology, cardiovascular surgery and general surgery. Most recently Greg was the Chairman, President and CEO of BÂRRX Medical a private medical device company recently acquired by Covidien. BÂRRX manufactures and distributes products to treat gastrointestinal diseases with specific focus on diseases of the esophagus.

Prior to joining BÂRRX Medical, Inc., Greg served as President and CEO of ACMI Corporation which was acquired by Gyrus Medical. Greg was previously a Group Executive Vice President at Boston Scientific Corporation with responsibilities at various times over the Microvasive Endoscopy, Microvasive Urology and Intercontinental International businesses. Greg has also held senior management positions at both Orthofix Corporation and Baxter Healthcare. He also spent 13 years at C.R. Bard Corporation and finished his tenure as Vice President of marketing in the Cardiosurgery Division.

Greg currently sits on the Board of Directors for Monteris Medical focused on the treatment of brain tumors, and Cutera, Inc. a public medical device company in the aesthetics market.

Greg holds a B.A. in Marketing from the University of Texas, Austin.